Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,387.20
(
0.59%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.44
(
-0.42%
)
Bitcoin
72,283.03
(
1.62%
)
News Focus
News Focus

Replies to post #636 on Bristol Myers Squibb (BMY)

Replies to #636 on Bristol Myers Squibb (BMY)
icon url

DewDiligence

09/07/17 9:39 AM

#637 RE: north40000 #636

The 41.6% figure refers to the Opdivo/Yervoy ORR of the 75% of patients in the trial who comprised the primary-endpoint analysis.